TradeUP Acquisition Corp. (UPTD) Shareholders Approve Estrella Deal
by Nicholas Alan Clayton on 2023-08-01 at 7:07am

TradeUP (NASDAQ:UPTD) announced in an 8-K this morning that its shareholders approved its combination with Estrella Biopharma at a special meeting yesterday, July 31.

650,580 shares were redeemed in connection with the vote, leaving the SPAC with just 98,074 public shares remaining from its original IPO. Should these results stand, TradeUp will have finished its process with 94.8% of shares redeemed.

In addition to its roughly $1 million in remaining trust capital, the SPAC also secured a $6.8 million PIPE last week. This effectively allowed Estrella lender Eureka Therapeutics to convert about $6.8 million in debts into equity in the form of 680,000 units, each containing one common share and one preferred share.

But, this is still short of the deal’s minimum cash condition, which requires TradeUp to maintain $20 million in cash available unless waived. The SPAC secured a one-year extension to its transaction deadline last month, however, so it has time to make additional moves to shore up this cash situation.

Should the deal go to close as is, these PIPE shares are to be locked up for one year, so they would not ease the low-float scenario that would face Estrella at close. Perhaps in anticipation of this, TradeUp stock spiked up to about +77% in pre-market trading at one point this morning.

What is likely to have an impact is the common stock purchase agreement TradeUp signed with White Lion Capital in April. Under this agreement, White Lion is to purchase up to $50 million in shares in the combined company after close. The maximum investment for agreement would appear to be unavailable even if White Lion may purchase shares recently tendered for redemption.

But, White Lion will nonetheless be issued 250,000 shares shortly after close in return for having made its commitments, which would more than triple Estrella’s liquid public share count.

TradeUp initially announced its $398 million combination with Estrella Biopharma in October 2022. Emeryville, California-based Estrella is developing three potential cancer therapies aimed at improving the effectiveness of T-cell treatments.

Recent Posts
by Nicholas Alan Clayton on 2024-07-17 at 8:40am

The use of forward projections by target companies going through a SPAC transaction has been a controversial topic since the SPAC boom began in 2020. But, left to the side of this issue has been the question, “Do de-SPACs even benefit from using projections?” Certainly plenty of de-SPACs have taken hits in the public markets...

by Nicholas Alan Clayton on 2024-07-17 at 8:28am

At the SPAC of Dawn Futures are starting the day deep red after hitting a string of highs this month, but many of the corners of the market populated by de-SPACs appear to have more room to roll. Small-caps overall are having a strong month as the Russell 2000 has surged forward nearly +11% over...

by Nicholas Alan Clayton on 2024-07-16 at 8:08am

At the SPAC of Dawn As the US elections draw nearer, more intersections of SPACs and politics are likely to continue to emerge. One day further into the Republican National Convention and Trump Media (NASDAQ:DJT) is now facing a slight -9% regression in the aftermarket, while conservative social media platform Rumble (NASDAQ:RUM) experienced its own...

by Nicholas Alan Clayton on 2024-07-15 at 3:53pm

Bleichroeder Acquisition Corp I (NASDAQ:BACQU) has filed to be the second SPAC brought to market by Santander in 2024, aiming to raise $250 million without the help of anchor investors. Many of Bleichroeder I’s terms are familiar in the current market with its trust initially funded to 100.0% with $10.00 in its units to start...

by Nicholas Alan Clayton on 2024-07-15 at 10:54am

Aquaron (NASDAQ:AQU) has entered into a definitive agreement to combine with hydrogen technology firm HUTURE at an initial equity value of about $1 billion. Shanghai-based HUTURE has developed technology for hydrogen fuel cell-powered heavy trucks and the refilling stations that would supply them. The combined company is expected to trade on the Nasdaq once the...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved